-+ 0.00%
-+ 0.00%
-+ 0.00%

Robert Baltera Bought 40% More Shares In Palisade Bio

Simply Wall St·11/21/2026 12:33:38
Listen to the news

Whilst it may not be a huge deal, we thought it was good to see that the Palisade Bio, Inc. (NASDAQ:PALI) Independent Director, Robert Baltera, recently bought US$50k worth of stock, for US$1.01 per share. That purchase might not be huge but it did increase their holding by 40%.

Palisade Bio Insider Transactions Over The Last Year

In fact, the recent purchase by Independent Director Robert Baltera was not their only acquisition of Palisade Bio shares this year. Earlier in the year, they paid US$2.05 per share in a US$102k purchase. That means that an insider was happy to buy shares at above the current price of US$0.84. While their view may have changed since the purchase was made, this does at least suggest they have had confidence in the company's future. To us, it's very important to consider the price insiders pay for shares. As a general rule, we feel more positive about a stock if insiders have bought shares at above current prices, because that suggests they viewed the stock as good value, even at a higher price.

Palisade Bio insiders may have bought shares in the last year, but they didn't sell any. They paid about US$1.69 on average. These transactions suggest that insiders have considered the current price attractive. You can see a visual depiction of insider transactions (by companies and individuals) over the last 12 months, below. By clicking on the graph below, you can see the precise details of each insider transaction!

Check out our latest analysis for Palisade Bio

insider-trading-volume
NasdaqCM:PALI Insider Trading Volume November 21st 2026

Palisade Bio is not the only stock that insiders are buying. For those who like to find small cap companies at attractive valuations, this free list of growing companies with recent insider purchasing, could be just the ticket.

Does Palisade Bio Boast High Insider Ownership?

I like to look at how many shares insiders own in a company, to help inform my view of how aligned they are with insiders. Usually, the higher the insider ownership, the more likely it is that insiders will be incentivised to build the company for the long term. From looking at our data, insiders own US$3.7m worth of Palisade Bio stock, about 2.2% of the company. We consider this fairly low insider ownership.

What Might The Insider Transactions At Palisade Bio Tell Us?

It is good to see recent purchasing. We also take confidence from the longer term picture of insider transactions. But we don't feel the same about the fact the company is making losses. While the overall levels of insider ownership are below what we'd like to see, the history of transactions imply that Palisade Bio insiders are reasonably well aligned, and optimistic for the future. So while it's helpful to know what insiders are doing in terms of buying or selling, it's also helpful to know the risks that a particular company is facing. At Simply Wall St, we've found that Palisade Bio has 5 warning signs (2 can't be ignored!) that deserve your attention before going any further with your analysis.

But note: Palisade Bio may not be the best stock to buy. So take a peek at this free list of interesting companies with high ROE and low debt.

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.